Frequency offset dependence of adiabatic rotating frame relaxation rate constants: relevance to MRS investigations of metabolite dynamics in vivo.
In this work, we investigated the frequency-offset dependence of the rotating frame longitudinal (R(1ρ)) and transverse (R(2ρ)) relaxation rate constants when using hyperbolic-secant adiabatic full passage pulses or continuous-wave spin-lock irradiation. Phantom and in vivo measurements were performed to validate theoretical predictions of the dominant relaxation mechanisms existing during adiabatic full passage pulses when using different settings of the frequency offset relative to the carrier. In addition, adiabatic R(1ρ) and R(2ρ) values of total creatine and N-acetylaspartate were measured in vivo from the human brain at 4 T. When the continuous-wave pulse power was limited to safe specific absorption rates for humans, simulations revealed a strong dependence of R(1ρ) and R(2ρ) values on the frequency offset for both dipolar interactions and anisochronous exchange mechanisms. By contrast, theoretical and experimental results showed adiabatic R(1ρ) and R(2ρ) values to be practically invariant within the large subregion of the bandwidth of the hyperbolic-secant pulse where complete inversion was achieved. However, adiabatic R(1ρ) and R(2ρ) values of the methyl protons of total creatine (at 3.03 ppm) were almost doubled when compared with those of the methyl protons of N-acetylaspartate (at 2.01 ppm) in spite of the fact that these resonances were in the flat region of the inversion band of the adiabatic full passage pulses. We conclude that differences in adiabatic R(1ρ) and R(2ρ) values of human brain metabolites are not a result of their chemical shifts, but instead reflect differences in dynamics.
Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota School of Medicine, Minneapolis, MN 55455, USA. mangia@cmrr.umn.edu
Silvia
S
Mangia
Timo
T
Liimatainen
Michael
M
Garwood
Ivan
I
Tkac
Pierre-Gilles
PG
Henry
Dinesh
D
Deelchand
Shalom
S
Michaeli
D000465:Algorithms; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000033:anatomy & histology / Q000378:metabolism*; D001931:Brain Mapping / Q000379:methods; D003401:Creatine / Q000378:metabolism; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008962:Models, Theoretical; D019047:Phantoms, Imaging; D011522:Protons
D011522:Protons; D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine
Magn Reson Med. 2010 Oct;64(4):983-94
20740665
NMR Biomed. 2000 May;13(3):129-53
10861994
J Magn Reson. 2004 Aug;169(2):293-9
15261625
Magn Reson Med. 1995 Feb;33(2):246-52
7707916
Magn Reson Med. 2006 Feb;55(2):250-7
16402370
J Magn Reson. 2001 Dec;153(2):155-77
11740891
J Neurochem. 2004 Nov;91(4):778-87
15525331
Methods Enzymol. 2001;339:204-38
11462813
J Magn Reson. 2006 Jul;181(1):135-47
16675277
J Magn Reson B. 1994 Jul;104(3):266-75
8069484
J Magn Reson. 2007 May;186(1):75-85
17291799
Magn Reson Med. 2004 May;51(5):875-80
15122667
Magn Reson Med. 2005 Apr;53(4):823-9
15799068
Magn Reson Med. 2000 Feb;43(2):319-23
10680699
J Magn Reson. 2004 Sep;170(1):104-12
15324763
J Am Chem Soc. 2010 Jul 28;132(29):9979-81
20590094
Magn Reson Imaging. 2009 Oct;27(8):1074-87
19559559
Magn Reson Med. 2008 Jun;59(6):1311-9
18506797
Magn Reson Med. 1999 Apr;41(4):649-56
10332839